Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Detroit MI, Livonia MI, Clinton Township MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase2, Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Detroit MI, Grand Rapids MI, Toronto, Chicago IL,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase1, Phase2, Recruiting

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: Detroit MI
Sponsor: Celcuity Inc

Sex: Male

Age: 18+

Code: NCT06190899

Phase1, Phase2, Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Madison WI,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase1, Phase2, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Detroit MI, Dearborn MI, Wyandotte MI, Brownstown MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

for
Severe Aplastic Anemia
Location: Detroit MI, Columbus OH, Milwaukee WI, Baltimore MD,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70+

Code: NCT06517641

Phase2, Recruiting

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

for
Kidney Cancer
Location: Detroit MI, Pittsburgh PA, Indianapolis IN, Maywood IL,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT00301990

Phase2, Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Detroit MI, Madison Heights MI, Brownstown MI, Troy MI,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase3, Recruiting

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Detroit MI, Royal Oak MI, Farmington Hills MI,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 60+

Code: NCT05976763

Phase3, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Columbus OH,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Detroit MI, Hilliard OH, Centerville OH, Pittsburgh PA,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase2, Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Detroit MI, Dearborn MI, Madison Heights MI, Warren MI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05624996

Phase3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Detroit MI, Toronto, Pittsburgh PA, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase3, Recruiting

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

for
Metastatic Lung Small Cell Carcinoma,
Location: Detroit MI, Livonia MI, Mount Clemens MI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT04804644

Phase3, Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Chicago IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06385080

Phase1, Phase2, Recruiting

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

for
Breast Cancer, Breast Cancer Metastatic,
Location: Detroit MI, Canton OH, Fort Wayne IN, Buffalo NY,
Sponsor: Incyclix Bio

Sex: All

Age: 18+

Code: NCT05735080

Phase1, Phase2, Recruiting

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

for
Small Cell Lung Cancer, Advanced Solid Malignant Tumor
Location: Detroit MI, Canton OH, Fairfax VA, Nashville TN,
Sponsor: Chipscreen Biosciences, Ltd.

Sex: All

Age: 18+

Code: NCT05271292

Phase1, Phase2, Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

for
Endometrial Cancer
Location: Detroit MI, Pittsburgh PA, Buffalo NY, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: Female

Age: 18 - 70

Code: NCT06481592

Phase2, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Detroit MI, Farmington Hills MI, Lansing MI,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase2, Recruiting

Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study

for
Vascular Access Complication, Vascular Access Related Infection
Location: Detroit MI, Lexington KY
Sponsor: Teleflex

Sex: All

Age: 18+

Code: NCT03019302

Recruiting